Home › NDC Lookup › RxCUI directory › RxCUI 2262446

Zanubrutinib 80 MG Oral Capsule [Brukinsa] — RxCUI 2262446

RxNorm drug concept · Semantic branded drug
RxCUI 2262446 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2262446
Official nameZanubrutinib 80 MG Oral Capsule [Brukinsa]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBrukinsa 80 MG Oral Capsule
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)3,956 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Zanubrutinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats certain B-cell cancers in adults: mantle cell lymphoma, Waldenström's macroglobulinemia, marginal zone lymphoma, chronic lymphocytic leukemia or small lymphocytic lymphom...
  • Take Brukinsa by mouth, once or twice a day as prescribed, with or without food. Swallow it whole with water. Don't open, break or chew capsules, and don't chew or crush tablets. I...
  • Common ones include low white blood cell and platelet counts, colds and other upper respiratory infections, bruising or bleeding, muscle and joint pain, and rash. Your doctor will...
  • Call for fever or signs of infection, unusual or severe bleeding, black or bloody stools, a severe headache, a racing or irregular heartbeat, fainting, chest discomfort, or signs o...
📖 Read our full Zanubrutinib guide →

🕸️ Concept Web — How Zanubrutinib 80 MG Oral Capsule [Brukinsa] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zanubrutinib 80 MG Oral Capsule [Brukinsa] RxCUI 2262446

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Zanubrutinib 2262435
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Brukinsa 2262441
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zanubrutinib Oral Capsule 2262439
    • Zanubrutinib Oral Product 2262437
    • Zanubrutinib Pill 2262438
    • Zanubrutinib Oral Capsule [Brukinsa] 2262443
    • Brukinsa Oral Product 2262444
    • Brukinsa Pill 2262445
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zanubrutinib 80 MG Oral Capsule SCD · 2262440
  • Zanubrutinib 80 MG SCDC · 2262436
  • Zanubrutinib Oral Capsule SCDF · 2262439
  • Zanubrutinib Oral Product SCDG · 2262437
  • Zanubrutinib Pill SCDG · 2262438

Brand-Name Concepts

  • Zanubrutinib 80 MG [Brukinsa] SBDC · 2262442
  • Zanubrutinib Oral Capsule [Brukinsa] SBDF · 2262443
  • Brukinsa Oral Product SBDG · 2262444
  • Brukinsa Pill SBDG · 2262445
  • Brukinsa BN · 2262441

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2262446 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72579-0011-02 1 BOTTLE, PLASTIC in 1 CARTON (72579-011-02) / 120 CAPSULE... BRUKINSA BeOne Medicines USA, Inc. 2019-11-14
72579-0122-01 1 BOTTLE in 1 CARTON (72579-122-01) / 60 TABLET, FILM COATE... BRUKINSA BeOne Medicines USA, Inc. 2025-08-18
Observed labelers: BeOne Medicines USA, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.